Weill Cornell Chelsea CRS (7804) — New York, New York

Weill Cornell Chelsea CRS (7804) is a clinical research site located in New York, New York, United States 10010.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Weill Cornell Chelsea CRS (7804) has participated in 5 clinical trials.

Therapeutic areas: HIV Infections, HIV-1 Infection, Hepatitis C Infection.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Weill Cornell Chelsea CRS (7804)?

Weill Cornell Chelsea CRS (7804) has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Weill Cornell Chelsea CRS (7804) conducted?

Weill Cornell Chelsea CRS (7804) has 5 clinical trials on record. Their work covers HIV Infections, HIV-1 Infection, Hepatitis C Infection.

Is Weill Cornell Chelsea CRS (7804) accredited by Crixeo Health?

Weill Cornell Chelsea CRS (7804) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Weill Cornell Chelsea CRS (7804)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.